BackPacira BioSciences Overview

Pacira BioSciences Accounts Payable

Pacira BioSciences's accounts payable is $18M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$17.51M
41.88% YoYΔ $-12.62M vs prior year quarter

Peer trimmed avg / median

Loading

Pacira BioSciences Accounts Payable History

Loading

Pacira BioSciences vs. peers: Accounts Payable Comparison

Loading

Pacira BioSciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pacira BioSciences (PCRX) FAQ

As of the most recent data (June 2026), PCRX shows a accounts payable of $18M. That compares with $30M in the prior-year period — down 41.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PCRX's accounts payable is now $18M (was $30M) — a 41.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pacira BioSciences is outperforming or lagging.

Tracking PCRX's accounts payable over time shows whether Pacira BioSciences is scaling, shrinking, or reshaping that part of the business. The current reading is $18M That compares with $30M in the prior-year period — down 41.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Pacira BioSciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $18M) with ownership activity and broader fundamentals.

Pacira BioSciences's accounts payable is $18M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.